Results
1 -
10 of
13Class IC Antiarrhythmic Agents: Status ? 1984, Cardiac Arrhythmias: New Therapeutic Drugs and Devices Is There a Rational Basis for the Modified Classification of Antiarrhythmic Drugs?, Cardiac Arrhythmias: New Therapeutic Drugs and Devices Clinical Use of Class Ic Antiarrhythmic Drugs, Antiarrhythmic Drugs Indecainide: suppresses PVCs as effectively as quinidine but proarrhythmic potential may be a problem, InPharma Indecainide: an effective antiarrhythmic in selected patients but with potentially serious side effects, InPharma Indecainide: suppresses ventricular ectopic beats but ventricular tachycardia is poorly controlled, InPharma Indecainide: effective in a small number of patients presenting with severe arrhythmias, InPharma Indecainide: appears effective and well tolerated in the prophylaxis of benign or potentially lethal ventricular arrhythmias, InPharma Indecainide: produces favourable electrophysiological effects and appears safe, InPharma Multivariate analysis of experimental and computational descriptors of molecular lipophilicity, Journal of Computer-Aided Molecular Design